)
MOHCCN Seminar Series
This seminar series features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. These seminars will be of interest primarily to cancer researchers, clinicians, trainees, and members of the MOHCCN Patient Working Group across the country.
Upcoming seminars
Next: Thursday, March 20th 2025 - Ontario
9am PT / 10am MT / 11am CT / 12pm ET / 1pm AT / 1:30pm NT
Agenda
Consortium Activities Update
Lillian Siu, MD, FRCPC - Medical oncologist, Princess Margaret Cancer Centre, University Health Network; MOHCCN consortium lead
Research Presentations
Bringing whole genome transcriptome sequencing (WGTS) to patient care and clinicians: the prospective MOHCCN-O study and Molecular Tumor Board at PM2C.
Enrique Sanz-Garcia, MD, PhD - Medical oncologist and clinician-investigator, Princess Margaret Cancer Centre, University Health Network; MOHCCN consortium lead
Evaluating shallow Whole Genome Sequencing (sWGS) Prior to deep-WGS Assays to Estimate Tumor Purity in Oncology
Carlos Diego Holanda Lopes, MD - Clinical research fellow, supervised by Jeffrey Bruce, PhD and Philippe Bedard, MD, Princess Margaret Cancer Centre, University Health Network
This event will be co-chaired by a member of the MOHCCN Patient Working Group and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.
The remaining 2025 MOHCCN seminars are tentatively scheduled for the following dates:
May 29: Marathon of Hope - Québec (MOH-Q) consortium
June 26: BC Cancer Consortium (BC2C)
September 25 - Prairie Cancer Consortium (PR2C)
October 30 - Atlantic Cancer Consortium (ACC)
November 27 - Pan-Canadian projects